Matches in Wikidata for { <http://www.wikidata.org/entity/Q89408421> ?p ?o ?g. }
- Q89408421 description "2018 nî lūn-bûn" @default.
- Q89408421 description "2018年の論文" @default.
- Q89408421 description "2018年学术文章" @default.
- Q89408421 description "2018年学术文章" @default.
- Q89408421 description "2018年学术文章" @default.
- Q89408421 description "2018年学术文章" @default.
- Q89408421 description "2018年学术文章" @default.
- Q89408421 description "2018年学术文章" @default.
- Q89408421 description "2018年學術文章" @default.
- Q89408421 description "2018年學術文章" @default.
- Q89408421 description "2018年學術文章" @default.
- Q89408421 description "2018年學術文章" @default.
- Q89408421 description "2018年學術文章" @default.
- Q89408421 description "2018년 논문" @default.
- Q89408421 description "article científic" @default.
- Q89408421 description "article scientific" @default.
- Q89408421 description "article scientifique" @default.
- Q89408421 description "articol științific" @default.
- Q89408421 description "articolo scientifico" @default.
- Q89408421 description "artigo científico" @default.
- Q89408421 description "artigo científico" @default.
- Q89408421 description "artigo científico" @default.
- Q89408421 description "artikel ilmiah" @default.
- Q89408421 description "artikull shkencor" @default.
- Q89408421 description "artikulong pang-agham" @default.
- Q89408421 description "artykuł naukowy" @default.
- Q89408421 description "artículo científico publicado en 2018" @default.
- Q89408421 description "artículu científicu" @default.
- Q89408421 description "bilimsel makale" @default.
- Q89408421 description "bài báo khoa học" @default.
- Q89408421 description "naučni članak" @default.
- Q89408421 description "scienca artikolo" @default.
- Q89408421 description "scientific article published on 30 June 2018" @default.
- Q89408421 description "scientific article published on 30 June 2018" @default.
- Q89408421 description "scientific article published on 30 June 2018" @default.
- Q89408421 description "teaduslik artikkel" @default.
- Q89408421 description "tieteellinen artikkeli" @default.
- Q89408421 description "tudományos cikk" @default.
- Q89408421 description "vedecký článok" @default.
- Q89408421 description "vetenskaplig artikel" @default.
- Q89408421 description "videnskabelig artikel udgivet 30. juni 2018" @default.
- Q89408421 description "vitenskapelig artikkel" @default.
- Q89408421 description "vitskapeleg artikkel" @default.
- Q89408421 description "vědecký článek" @default.
- Q89408421 description "wetenschappelijk artikel" @default.
- Q89408421 description "wissenschaftlicher Artikel" @default.
- Q89408421 description "επιστημονικό άρθρο" @default.
- Q89408421 description "мақолаи илмӣ" @default.
- Q89408421 description "наукова стаття, опублікована в червні 2018" @default.
- Q89408421 description "научна статия" @default.
- Q89408421 description "научная статья" @default.
- Q89408421 description "научни чланак" @default.
- Q89408421 description "научни чланак" @default.
- Q89408421 description "מאמר מדעי" @default.
- Q89408421 description "مقالة علمية نشرت في 30 يونيو 2018" @default.
- Q89408421 description "৩০ জুন ২০১৮-এ প্রকাশিত বৈজ্ঞানিক নিবন্ধ" @default.
- Q89408421 description "บทความทางวิทยาศาสตร์" @default.
- Q89408421 description "სამეცნიერო სტატია" @default.
- Q89408421 name "Corrigendum to 'Ramucirumab as second-line treatment in patients with advanced hepatocellular carcinoma following first-line therapy with sorafenib: Patient-focused outcome results from the randomised phase III REACH study' [Eur J Canc 81 (2017) 17-" @default.
- Q89408421 name "Corrigendum to 'Ramucirumab as second-line treatment in patients with advanced hepatocellular carcinoma following first-line therapy with sorafenib: Patient-focused outcome results from the randomised phase III REACH study' [Eur J Canc 81 (2017) 17-" @default.
- Q89408421 type Item @default.
- Q89408421 label "Corrigendum to 'Ramucirumab as second-line treatment in patients with advanced hepatocellular carcinoma following first-line therapy with sorafenib: Patient-focused outcome results from the randomised phase III REACH study' [Eur J Canc 81 (2017) 17-" @default.
- Q89408421 label "Corrigendum to 'Ramucirumab as second-line treatment in patients with advanced hepatocellular carcinoma following first-line therapy with sorafenib: Patient-focused outcome results from the randomised phase III REACH study' [Eur J Canc 81 (2017) 17-" @default.
- Q89408421 prefLabel "Corrigendum to 'Ramucirumab as second-line treatment in patients with advanced hepatocellular carcinoma following first-line therapy with sorafenib: Patient-focused outcome results from the randomised phase III REACH study' [Eur J Canc 81 (2017) 17-" @default.
- Q89408421 prefLabel "Corrigendum to 'Ramucirumab as second-line treatment in patients with advanced hepatocellular carcinoma following first-line therapy with sorafenib: Patient-focused outcome results from the randomised phase III REACH study' [Eur J Canc 81 (2017) 17-" @default.
- Q89408421 P1433 Q89408421-877AFB9A-C2B9-46E0-9D33-4F9F47499D26 @default.
- Q89408421 P1476 Q89408421-AA556753-8640-47CC-B66F-6736B6E3A65A @default.
- Q89408421 P2093 Q89408421-03B347F3-5987-479B-AB52-A80286FE7981 @default.
- Q89408421 P2093 Q89408421-0D4927C1-22E5-4131-8374-64319CE3B396 @default.
- Q89408421 P2093 Q89408421-17652B03-AA99-493A-AFD2-1CD505DEEE9D @default.
- Q89408421 P2093 Q89408421-230BF63E-22FE-49A9-93BA-350E64B92683 @default.
- Q89408421 P2093 Q89408421-2CAA5018-8E5C-431B-BD9B-7CAC0638F19C @default.
- Q89408421 P2093 Q89408421-326B4EF6-7132-46F0-BAF6-43F84CBBA09B @default.
- Q89408421 P2093 Q89408421-442FCA7E-5E59-4E25-A9A7-B692FBD86C95 @default.
- Q89408421 P2093 Q89408421-4ADEDEE2-5DD9-4852-9C8C-7FEE97027718 @default.
- Q89408421 P2093 Q89408421-4FEBAE1B-FA25-49A1-84FB-C3456FF52A8C @default.
- Q89408421 P2093 Q89408421-6482BE37-D303-4CF6-B685-35B62E7397A1 @default.
- Q89408421 P2093 Q89408421-65EE3219-FC6F-48DA-90C1-EA11A45804DB @default.
- Q89408421 P2093 Q89408421-6A0CE306-4C34-4F4E-A42B-DD5E695E47FA @default.
- Q89408421 P2093 Q89408421-6C45E1CD-0DE9-4A9C-906A-B7DE9ACFB9EC @default.
- Q89408421 P2093 Q89408421-84C172FB-94C7-4939-8C59-1198F1107923 @default.
- Q89408421 P2093 Q89408421-A87A3D6E-0931-4939-A0BF-2DCB5E088E0D @default.
- Q89408421 P2093 Q89408421-AA5F2017-4FCA-427B-B8AE-FA612BBCA098 @default.
- Q89408421 P2093 Q89408421-C3DB3641-D8D9-4774-B941-917CB057B530 @default.
- Q89408421 P2093 Q89408421-C50DC4B5-AC8A-4724-9033-5DD3DF148C4A @default.
- Q89408421 P2093 Q89408421-C5D143A2-AF03-4D11-99F3-9594437C9536 @default.
- Q89408421 P2093 Q89408421-D78585FE-3AB9-4C5B-80FB-7E97421E84FD @default.
- Q89408421 P304 Q89408421-BFEA468A-67FA-4291-A0D5-9B74FB9498DB @default.
- Q89408421 P31 Q89408421-2F99B06A-EBC9-41C1-A066-E49CCE7E9735 @default.
- Q89408421 P31 Q89408421-F46EEB1D-2796-4C70-8BFB-ED85BD2B42AF @default.
- Q89408421 P356 Q89408421-5E63C0F3-E688-43E0-A7D2-02FACDC50246 @default.
- Q89408421 P478 Q89408421-50154D0D-ED6B-4079-8459-AB1470FB6703 @default.
- Q89408421 P50 Q89408421-D62FA486-1B22-4675-B33E-1A82855B3229 @default.
- Q89408421 P577 Q89408421-655E07A0-E262-499A-8F99-838A8D5035F1 @default.
- Q89408421 P698 Q89408421-C9687521-71C2-4528-868E-65429BE0D76C @default.
- Q89408421 P356 J.EJCA.2018.06.002 @default.
- Q89408421 P698 29970352 @default.
- Q89408421 P1433 Q332260 @default.
- Q89408421 P1476 "Corrigendum to 'Ramucirumab as second-line treatment in patients with advanced hepatocellular carcinoma following first-line therapy with sorafenib: Patient-focused outcome results from the randomised phase III REACH study' [Eur J Canc 81 (2017) 17-25]" @default.
- Q89408421 P2093 "Allicia C Girvan" @default.